Ignite Innovation Fund - aVenture Asset Manager Research
Location
London, Greater London, GB
Ignite Innovation Fund, based in London, focuses on early-stage investments, supporting founders with global ambitions. The firm typically participates in Convertible Note, Series A, and Series B rounds, providing financial backing to startups aiming to expand beyond their local markets.
Notable portfolio companies include Genome Insight and ImpriMed, each having raised $23 million. Ignite Innovation Fund prides itself on a hands-on investment philosophy, offering strategic guidance and leveraging an extensive network to help portfolio companies scale internationally. Key partners bring significant industry experience and connections, enhancing the firm's value-add services.
Ignite Innovation Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series A1 (50.0%)
Series B1 (50.0%)
Stage Mix
Series A 50%Series B 50%
Concentration shown as share of disclosed investments by stage.